Parexel
Parexel is a global contract research organization that provides clinical research, regulatory, and consulting services to biopharmaceutical and medical device companies to support the development and commercialization of new therapies. The company manages clinical trials, data management, pharmacovigilance, and market access activities on an outsourced basis. Parexel generates revenue through long-term service contracts and project-based fees with life sciences clients worldwide.
- Clinical Trial & Research Software
- IT Consulting & Implementation
- Revenue
- $2.8B
- Employees
- 21,000
- Founded
- 1982
- Headquarters
- Durham, United States of America
What 82 Arbolus experts think of Parexel
Parexel displays a strong NPS performance with the majority of scores at 7-10, indicating solid promoter presence and generally positive user advocacy. Renewal intent is mixed: about half signal high likelihood to renew, but a significant cohort express uncertainty, particularly among mid to high spenders. Most participants are at a MoreThan1Year implementation stage, reflecting deep engagement and operational integration. Expert themes praise regulatory expertise, global coverage, and secure automation, but highlight cost and occasional continuity concerns. Overall Customer Sentiment: Positive
Who reviewed Parexel
- C-Suite 52% (43)
- Director 40% (33)
- Manager 8% (7)
Employer names and spend open in the full report, along with the other 79 customers.
Everything 82 customers told us about Parexel.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
-7 Net Promoter Score, from 82 scored reviews- Promoters 21
- Passives 34
- Detractors 27
Cumulative NPS by month
+0 over 6 months- Mar 7
- May 7
- Jun 7
- Jul 7
- Sep 7
- Oct 7
Net Promoter Score across 3 reviews, accumulated up to each month. Category median 27 across 3 companies.
Praised
- Mission-Critical Regulatory Support
- Operational Efficiency and Speed
- Unique Technology + Service Ecosystem
- Advanced Automation
Criticised
- Cost Concerns
- Team Continuity
- Need for Governance
- Disruption from Autonomous AI
What customers say
Renewal intent
Plan to renew 20%Plan to renew, by seniority
- 24% 37 answers
- 14% 29 answers
- 25% 4 answers
- 0% 1 answer
- 7.8/10 Average score from customers who will renew
- 7.1/10 Average score from undecided customers
- 6.6/10 Average score from customers not renewing
Top alternatives
Most weighed by Parexel customers
Report
More in Data & Analytics and Consulting & Professional Services
Other companies in both categories with a customer report.
For people who use Parexel
Do you use Parexel at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 82 customers of Parexel have already contributed
Takes a few minutes. Your identity stays anonymous.